Jin Wan Lin - Innovation (Stock Code: 6645), a company specializing in the Biotechnology and Medical Industry, has released its revenue figures for April 2026. The company reported a monthly revenue of 34,751 thousand TWD, approximately 35 million TWD. This represents a year-over-year decrease of 15.5% compared to the same month in the previous year. The decline in revenue suggests potential market headwinds or operational adjustments within the biotechnology and medical sector for the company.

FACT BOX

  • Source: PR Times
  • Category: News